Fiori Alite
Experienced in Lung Nodules

Dr. Fiori Alite

Radiation Oncology
Geisinger Health System
Geisinger Lewisburg - Radiation Oncology
75 Medical Park Drive, 
Lewisburg, PA 
Accepting New Patients
Offers Telehealth

Experienced in Lung Nodules
Geisinger Health System
Geisinger Lewisburg - Radiation Oncology
75 Medical Park Drive, 
Lewisburg, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dr. Alite is a board-certified and fellowship-trained cancer physician specializing in the lung, prostate and pediatric malignancies. His clinical interests include stereotactic radiosurgery, stereotactic body radiotherapy, prostate and gynecologic brachytherapy. His research interests include clinical innovation, patient-reported outcomes and stereotactic radiotherapy. Dr. Alite attended Drexel University, where he earned his medical degree and completed his residency at Loyola University Health System. He is certified by the American Board of Radiology in radiation oncology.

Dr. Alite is rated as an Experienced provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Laryngeal Cancer, and Muscle Invasive Bladder Cancer.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Drexel University College Of Medicine - GME Office, 2011 - Doctor Of Medicine
Specialties
Radiation Oncology
Licenses
Radiology in IL
Board Certifications
The American Board Of Radiology In Radiation Oncology
Hospital Affiliations
Geisinger St. Luke's Hospital
Geisinger Medical Center
Geisinger-Bloomsburg Hospital
Wellspan Evangelical Community Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Geisinger Lewisburg - Radiation Oncology
75 Medical Park Drive, Lewisburg, PA 17837
Call: 800-275-6401
Other Locations
Geisinger Medical Center - Radiation Oncology
100 North Academy Avenue, Danville, PA 17822
Call: 800-275-6401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)
Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)
Enrollment Status: Terminated
Publish Date: August 17, 2025
Intervention Type: Procedure, Other, Biological, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 2
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: August 05, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 5 Less Clinical Trials

18 Total Publications

Development of Radiographic Radiation Pneumonitis (RP) in Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy (SBRT) May Be Protective Against Further Disease Progression.
Development of Radiographic Radiation Pneumonitis (RP) in Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy (SBRT) May Be Protective Against Further Disease Progression.
Journal: Cureus
Published: June 15, 2022
View All 18 Publications
Similar Doctors
Eric J. Kemmerer
Experienced in Lung Nodules
Dr. Eric J. Kemmerer
Radiation Oncology
Experienced in Lung Nodules
Dr. Eric J. Kemmerer
Radiation Oncology

GWVMC Radiation Oncology

1000 East Mountain Boulevard, 
Wilkes Barre, PA 
 (59.2 miles away)
570-808-7075
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Kemmerer is a board-certified cancer physician whose clinical interests include cancer of the lung, breast and prostate. He attended Temple University School of Medicine, where he earned his medical degree. He completed residencies at Wayne State University and Drexel University College of Medicine. Dr. Kemmerer is certified by the American Board of Radiology in radiation oncology. Dr. Kemmerer is rated as a Distinguished provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Experienced in Lung Nodules
Dr. Veeral B. Patel
Radiation Oncology
Experienced in Lung Nodules
Dr. Veeral B. Patel
Radiation Oncology

Mount Nittany Medical Center Health Services Inc

141 Medical Park Ln, 
Bellefonte, PA 
 (44.9 miles away)
814-355-7322
Languages Spoken:
English
See accepted insurances

Veeral Patel is a Radiation Oncologist in Bellefonte, Pennsylvania. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Experienced in Lung Nodules
Dr. Gregory A. Fortier
Radiation Oncology | Radiology
Experienced in Lung Nodules
Dr. Gregory A. Fortier
Radiation Oncology | Radiology

Wellspan Medical Group

850 Tuck St, 
Lebanon, PA 
 (52.0 miles away)
717-639-3662
Languages Spoken:
English
See accepted insurances

Gregory Fortier is a Radiation Oncologist and a Radiologist in Lebanon, Pennsylvania. Dr. Fortier is rated as an Advanced provider by MediFind in the treatment of Lung Nodules. His top areas of expertise are Laryngeal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer.

VIEW MORE LUNG NODULES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Alite's expertise for a condition
ConditionClose
    • Distinguished
    • Laryngeal Cancer
      Dr. Alite is
      Distinguished
      . Learn about Laryngeal Cancer.
      See more Laryngeal Cancer experts
    • Lung Cancer
      Dr. Alite is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Pleuropulmonary Blastoma
      Dr. Alite is
      Distinguished
      . Learn about Pleuropulmonary Blastoma.
      See more Pleuropulmonary Blastoma experts
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Alite is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Breast Cancer
      Dr. Alite is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Alite is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Familial Pancreatic Cancer
      Dr. Alite is
      Advanced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Familial Prostate Cancer
      Dr. Alite is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Large-Cell Lung Carcinoma
      Dr. Alite is
      Advanced
      . Learn about Large-Cell Lung Carcinoma.
      See more Large-Cell Lung Carcinoma experts
    View All 14 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Alite is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Adenoid Cystic Carcinoma
      Dr. Alite is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Alite is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Alite is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Anal Cancer
      Dr. Alite is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Angiosarcoma
      Dr. Alite is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    View All 55 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.